Cargando…
Cell therapy using tolerogenic dendritic cells in transplantation
Organ transplantation is the main alternative to the loss of vital organ function from various diseases. However, to avoid graft rejection, transplant patients are treated with immunosuppressive drugs that have adverse side effects. A new emerging approach to reduce the administration of immunosuppr...
Autores principales: | Moreau, Aurélie, Varey, Emilie, Bouchet-Delbos, Laurence, Cuturi, Maria-Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560975/ https://www.ncbi.nlm.nih.gov/pubmed/23369513 http://dx.doi.org/10.1186/2047-1440-1-13 |
Ejemplares similares
-
Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials
por: Moreau, Aurélie, et al.
Publicado: (2012) -
Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
por: Marín, Eros, et al.
Publicado: (2018) -
Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies
por: Suuring, Maaike, et al.
Publicado: (2021) -
Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal Blockage
por: Silva, Priscila de Matos, et al.
Publicado: (2015) -
Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
por: Zhuang, Quan, et al.
Publicado: (2020)